Evergreen Reporter

FDA conducted third highest number of inspections on Veterinary companies in Washington during 2023

By Evergreen Reporter | Apr 26, 2024

The U.S. Food and Drug Administration (FDA) conducted 14 inspections at 14 Veterinary companies from Washington in 2023.

Washington: Tobacco companies were the least FDA inspected companies in Washington in 2023

By Evergreen Reporter | Apr 25, 2024

The U.S. Food and Drug Administration (FDA) conducted two inspections at two Tobacco companies from Washington in 2023.

Report: Washington ranked No. 30 for per-capita credit card fraud reports in 2023

By Evergreen Reporter News Service | Apr 25, 2024

Washington ranked No. 30 in the country for per-capita credit card fraud reports in 2023.

Which type of Washington companies were inspected the most by FDA in 2023?

By Evergreen Reporter | Apr 24, 2024

The U.S. Food and Drug Administration (FDA) conducted 174 inspections at 154 Food and Cosmetics companies from Washington in 2023.

Washington: Drugs companies were the third least FDA inspected companies in Washington in 2023

By Evergreen Reporter | Apr 23, 2024

The U.S. Food and Drug Administration (FDA) conducted nine inspections at nine Drugs companies from Washington in 2023.

69 Washington hospitals participate in federal 340B Drug Pricing Program

By Evergreen Reporter | Apr 23, 2024

Washington has 69 hospitals in the federal 340B Drug Pricing Program.

FDA conducted second lowest number of inspections on device companies in Washington during 2023

By Evergreen Reporter | Apr 22, 2024

The U.S. Food and Drug Administration (FDA) conducted seven inspections at seven device companies from Washington in 2023.

Washington: Biologics companies were the second most FDA inspected companies in Washington in 2023

By Evergreen Reporter | Apr 21, 2024

The U.S. Food and Drug Administration (FDA) conducted 16 inspections at 16 Biologics companies from Washington in 2023.

VA’s Interest Rate Reduction Refinance Loans in the state of Washington average $477,731 for Q1

By Evergreen Reporter | Apr 16, 2024

The VA’s Interest Rate Reduction Refinance Loans in Washington for the first quarter of the fiscal year 2024 averaged $477,731, according to figures provided by the Veterans Affairs Home Loans Index.

Number of VA loans issued in the state of Washington decreased by 28% from Q1 2023 to Q1 2024

By Evergreen Reporter | Apr 15, 2024

The U.S. Department of Veterans Affairs (VA) issued 2,101 home loans totaling $1 billion in Washington during the first quarter of the fiscal year 2024, according to figures provided by the Veterans Affairs Home Loans Index.

VA Purchase Loans in Washington average $498,471 for Q1

By Evergreen Reporter | Apr 15, 2024

The average VA Purchase Loan amount for Washington in the first quarter of fiscal year 2024 was $498,471, according to figures provided by the Veterans Affairs Home Loans Index.

Individual income tax revenue down 95.1% from previous quarter in the state of Washington

By Evergreen Reporter | Apr 5, 2024

The third quarter of 2023 brought in $41 million in individual income tax revenue for Washington, a 95.1% decrease from the second quarter of 2023, according to the U.S. Census Bureau's Quarterly Summary of State and Local Taxes.

Tax Revenue Analysis: The state of Washington collects $7.2 billion in sales and gross receipt tax during Q3 2023

By Evergreen Reporter | Apr 3, 2024

The state of Washington collected $7.2 billion in tax and gross receipts, according to the U.S. Census Bureau

Washington: Devices companies were the least FDA inspected companies in Washington in March

By Evergreen Reporter | Apr 2, 2024

The U.S. Food and Drug Administration (FDA) conducted an inspection at one Devices company from Washington in March.

FDA Inspection: What type of Washington companies were under most scrutiny during March?

By Evergreen Reporter | Apr 1, 2024

The U.S. Food and Drug Administration (FDA) conducted eight inspections at eight Food and Cosmetics companies from Washington in March.

Washington inflation under national average as of March 2024